Cargando…
Evaluation of Paraoxonase, Arylesterase, and Homocysteine Thiolactonase Activities in Patients with Diabetes and Incipient Diabetes Nephropathy
BACKGROUND: The aim of this study is to examine the relationship among the changes in activities of paraoxonase (PON), arylesterase (ARE) and homocysteine thiolactonase (HTLase) enzyme having antioxidant properties and the development of diabetic nephropathy (DN), one of the most common complication...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sciendo
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708292/ https://www.ncbi.nlm.nih.gov/pubmed/31496913 http://dx.doi.org/10.2478/jomb-2019-0014 |
_version_ | 1783445992219082752 |
---|---|
author | Ayan, Durmuş Şeneş, Mehmet Çaycı, Ayşe Banu Söylemez, Sibel Eren, Nezaket Altuntaş, Yüksel Öztürk, Feyza Yener |
author_facet | Ayan, Durmuş Şeneş, Mehmet Çaycı, Ayşe Banu Söylemez, Sibel Eren, Nezaket Altuntaş, Yüksel Öztürk, Feyza Yener |
author_sort | Ayan, Durmuş |
collection | PubMed |
description | BACKGROUND: The aim of this study is to examine the relationship among the changes in activities of paraoxonase (PON), arylesterase (ARE) and homocysteine thiolactonase (HTLase) enzyme having antioxidant properties and the development of diabetic nephropathy (DN), one of the most common complications of diabetes. METHODS: Normoalbuminuric type-2 diabetic patients (Group II, n=100), microalbuminuric type 2 diabetic patients (Group III, n=100) and the control group (Group I, n=100) were included in the study. The age and gender of the patient groups matched with the age and gender of the control group. HTLase, PON and ARE enzyme activities were measured by the spectrophotometric method using a g-thiobutyrinolactone, paraoxon, and phenylacetate substrates respectively. In this study, an autoanalyzer application was developed in order to measure HTLase enzyme activity for the first time. RESULTS: Serum HTLase, ARE and PON activities of Group III and Group II were significantly low compared to HTLase, ARE and PON results of Group I (p<0.05). CONCLUSIONS: Based on our results, PON, ARE and HTLase enzyme activities were found to be decreased due to the increase in the degree of DN. |
format | Online Article Text |
id | pubmed-6708292 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Sciendo |
record_format | MEDLINE/PubMed |
spelling | pubmed-67082922019-09-06 Evaluation of Paraoxonase, Arylesterase, and Homocysteine Thiolactonase Activities in Patients with Diabetes and Incipient Diabetes Nephropathy Ayan, Durmuş Şeneş, Mehmet Çaycı, Ayşe Banu Söylemez, Sibel Eren, Nezaket Altuntaş, Yüksel Öztürk, Feyza Yener J Med Biochem Original Paper BACKGROUND: The aim of this study is to examine the relationship among the changes in activities of paraoxonase (PON), arylesterase (ARE) and homocysteine thiolactonase (HTLase) enzyme having antioxidant properties and the development of diabetic nephropathy (DN), one of the most common complications of diabetes. METHODS: Normoalbuminuric type-2 diabetic patients (Group II, n=100), microalbuminuric type 2 diabetic patients (Group III, n=100) and the control group (Group I, n=100) were included in the study. The age and gender of the patient groups matched with the age and gender of the control group. HTLase, PON and ARE enzyme activities were measured by the spectrophotometric method using a g-thiobutyrinolactone, paraoxon, and phenylacetate substrates respectively. In this study, an autoanalyzer application was developed in order to measure HTLase enzyme activity for the first time. RESULTS: Serum HTLase, ARE and PON activities of Group III and Group II were significantly low compared to HTLase, ARE and PON results of Group I (p<0.05). CONCLUSIONS: Based on our results, PON, ARE and HTLase enzyme activities were found to be decreased due to the increase in the degree of DN. Sciendo 2019-03-26 /pmc/articles/PMC6708292/ /pubmed/31496913 http://dx.doi.org/10.2478/jomb-2019-0014 Text en © 2019 Durmuş Ayan, Mehmet Şeneş, Ayşe Banu Çaycı, Sibel Söylemez, Nezaket Eren, Yüksel Altuntaş, Feyza Yener Öztürk published by sciendo http://creativecommons.org/licenses/by-nc-nd/4.0 This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License. |
spellingShingle | Original Paper Ayan, Durmuş Şeneş, Mehmet Çaycı, Ayşe Banu Söylemez, Sibel Eren, Nezaket Altuntaş, Yüksel Öztürk, Feyza Yener Evaluation of Paraoxonase, Arylesterase, and Homocysteine Thiolactonase Activities in Patients with Diabetes and Incipient Diabetes Nephropathy |
title | Evaluation of Paraoxonase, Arylesterase, and Homocysteine Thiolactonase Activities in Patients with Diabetes and Incipient Diabetes Nephropathy |
title_full | Evaluation of Paraoxonase, Arylesterase, and Homocysteine Thiolactonase Activities in Patients with Diabetes and Incipient Diabetes Nephropathy |
title_fullStr | Evaluation of Paraoxonase, Arylesterase, and Homocysteine Thiolactonase Activities in Patients with Diabetes and Incipient Diabetes Nephropathy |
title_full_unstemmed | Evaluation of Paraoxonase, Arylesterase, and Homocysteine Thiolactonase Activities in Patients with Diabetes and Incipient Diabetes Nephropathy |
title_short | Evaluation of Paraoxonase, Arylesterase, and Homocysteine Thiolactonase Activities in Patients with Diabetes and Incipient Diabetes Nephropathy |
title_sort | evaluation of paraoxonase, arylesterase, and homocysteine thiolactonase activities in patients with diabetes and incipient diabetes nephropathy |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708292/ https://www.ncbi.nlm.nih.gov/pubmed/31496913 http://dx.doi.org/10.2478/jomb-2019-0014 |
work_keys_str_mv | AT ayandurmus evaluationofparaoxonasearylesteraseandhomocysteinethiolactonaseactivitiesinpatientswithdiabetesandincipientdiabetesnephropathy AT senesmehmet evaluationofparaoxonasearylesteraseandhomocysteinethiolactonaseactivitiesinpatientswithdiabetesandincipientdiabetesnephropathy AT caycıaysebanu evaluationofparaoxonasearylesteraseandhomocysteinethiolactonaseactivitiesinpatientswithdiabetesandincipientdiabetesnephropathy AT soylemezsibel evaluationofparaoxonasearylesteraseandhomocysteinethiolactonaseactivitiesinpatientswithdiabetesandincipientdiabetesnephropathy AT erennezaket evaluationofparaoxonasearylesteraseandhomocysteinethiolactonaseactivitiesinpatientswithdiabetesandincipientdiabetesnephropathy AT altuntasyuksel evaluationofparaoxonasearylesteraseandhomocysteinethiolactonaseactivitiesinpatientswithdiabetesandincipientdiabetesnephropathy AT ozturkfeyzayener evaluationofparaoxonasearylesteraseandhomocysteinethiolactonaseactivitiesinpatientswithdiabetesandincipientdiabetesnephropathy |